TargEDys
Saulx-les-chartreux
About TargEDys
TargEDys develops mechanisms involving hormone mimetic proteins linked to microbiota for the treatment of eating disorders such as hyperphagia or anorexia. The company was incorporated in 2011 and is based in Rouen, Fran
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $10.3M
- Funding stage: Early Stage Venture
- Last round: Series A (Apr 2017)
- Website: targedys.com
- Phone: +33 17-248-8457
Industries & Categories
Biotechnology, Health Care, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/targedys-136249 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.